Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
| Price | $1.31 |
|---|---|
| Market cap | $127.8M |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | AMEX |
| 52-week range | 1.24-3.59 |
| Beta | 1.42 |
Explore STXS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.